CN Stock MarketDetailed Quotes
603963 Dali Pharmaceutical
- 2.80
- -0.14-4.76%
Market Closed Nov 1 15:00 CST
615.16MMarket Cap-25225P/E (TTM)
2.93High2.79Low64.51KlotVolume2.91Open2.94Pre Close18.29MTurnover2.94%Turnover RatioLossP/E (Static)219.70MShares15.9752wk High1.70P/B615.16MFloat Cap2.2852wk Low3.09Limit Up219.70MShs Float21.25Historical High2.79Limit Down4.76%Amplitude2.28Historical Low--Dividend TTM2.83Avg Price39.89KlotAsk--Div YieldTTM100Lot Size22.28KlotBid
Dali Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 1,153.73%207.69M | 39.95%139.4M | -28.63%39.68M | -67.62%14.19M | -63.40%16.57M | 94.54%99.61M | -15.30%55.6M | -75.73%43.84M | -9.73%45.26M | 21.72%51.21M |
| Transactional financial assets | ---- | -40.68%80.78M | -15.73%175.73M | -9.81%206.74M | -14.20%206.19M | -42.95%136.17M | -10.89%208.53M | 73.08%229.23M | -0.79%240.33M | -0.78%238.68M |
| Notes receivable and accounts receivable | 87.28%7.67M | -69.61%1.75M | -72.44%1.81M | -75.85%1.87M | -35.87%4.09M | -9.32%5.76M | -8.99%6.56M | -3.96%7.73M | -26.20%6.38M | -27.79%6.35M |
| -Notes receivable | ---- | -42.70%43.02K | ---- | 18.28%177.44K | -32.11%112.62K | -9.19%75.08K | 230.15%96.59K | --150.01K | -44.24%165.89K | -78.14%82.68K |
| -Accounts receivable | 92.57%7.67M | -69.97%1.71M | -72.03%1.81M | -77.72%1.69M | -35.97%3.98M | -9.32%5.68M | -9.97%6.46M | -5.83%7.58M | -25.56%6.22M | -25.52%6.27M |
| Other receivables (including interest and dividends) | 2.74%162.39K | -14.09%156.94K | -28.41%171.87K | 1.92%37.43K | -16.94%158.05K | -91.09%182.69K | -88.38%240.07K | -98.10%36.73K | -90.72%190.28K | -12.00%2.05M |
| -Other receivable | ---- | ---- | ---- | ---- | ---- | -91.09%182.69K | ---- | ---- | ---- | -12.00%2.05M |
| Advance payment | 434.87%1.94M | -95.09%328.36K | 7.75%410.43K | 97.28%547.23K | -35.15%362.56K | 1,303.90%6.69M | -90.88%380.91K | 593.76%277.39K | -89.80%559.06K | -87.21%476.49K |
| Inventories | 14.03%55.76M | 121.42%60.14M | 120.44%61.03M | 136.27%63.84M | 90.85%48.9M | -2.30%27.16M | 20.73%27.69M | 6.30%27.02M | -58.00%25.62M | -59.30%27.8M |
| Other current assets | -95.04%87.16K | --289.91 | --35.09K | 221.42%1.92M | --1.76M | ---- | ---- | --598.23K | ---- | ---- |
| Total current assets | -1.70%273.3M | 2.54%282.57M | -6.73%278.87M | -6.34%289.15M | -12.66%278.03M | -15.61%275.58M | -11.02%298.99M | -11.42%308.73M | -13.86%318.35M | -10.72%326.56M |
| Non Current assets | ||||||||||
| Investment real estate | -2.93%60.48M | -2.90%60.93M | -2.88%61.39M | -2.86%61.85M | --62.3M | --62.76M | --63.21M | --63.67M | ---- | ---- |
| Fixed assets | ---- | 1.11%78.16M | ---- | ---- | ---- | 46.94%77.3M | ---- | 39.69%82.02M | ---- | -14.65%52.61M |
| Constru in process | ---- | ---- | ---- | ---- | ---- | -93.27%5.36M | ---- | -95.04%3.82M | ---- | 12.18%79.75M |
| Intangible assets | -3.01%34.16M | -2.76%34.42M | -2.77%34.68M | -2.77%34.95M | -33.21%35.22M | -33.42%35.39M | -33.42%35.67M | -33.43%35.95M | -3.11%52.73M | -3.08%53.16M |
| Deferred tax assets | -30.37%3.91M | -23.92%4.32M | -26.05%4.94M | -31.43%4.87M | -20.84%5.61M | -17.79%5.68M | -7.28%6.68M | -4.37%7.1M | -12.18%7.09M | -4.19%6.91M |
| Usufruct assets | -38.68%1.29M | -35.45%1.49M | 810.03%1.69M | 154.81%1.9M | 61.12%2.1M | 24.06%2.31M | -92.31%185.96K | -75.00%743.83K | -66.43%1.3M | -58.21%1.86M |
| Other non current assets | -72.54%171K | -96.07%63.84K | -99.38%9.1K | -95.98%63.1K | --622.8K | --1.63M | --1.48M | --1.57M | ---- | ---- |
| Total non current assets | -5.34%176.9M | -5.80%179.38M | -4.67%182.47M | -5.22%184.69M | -3.23%186.88M | -1.98%190.42M | -2.71%191.4M | -2.66%194.87M | -2.45%193.12M | -2.49%194.27M |
| Total assets | -3.16%450.2M | -0.87%461.94M | -5.92%461.34M | -5.91%473.83M | -9.10%464.91M | -10.53%466M | -7.95%490.39M | -8.23%503.6M | -9.88%511.46M | -7.82%520.83M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | 24.38%11.46M | 6.57%10.3M | -1.48%10.04M | 11.99%10.19M | -51.90%9.21M | -49.43%9.66M | -42.92%10.19M | -62.91%9.1M | -35.01%19.15M | -39.41%19.11M |
| -Accounts payable | 24.38%11.46M | 6.57%10.3M | -1.48%10.04M | 11.99%10.19M | -51.90%9.21M | -49.43%9.66M | -42.92%10.19M | -62.91%9.1M | -35.01%19.15M | -39.41%19.11M |
| Contract liabilities | 2,430.43%26.43M | 2,041.85%27.89M | 931.49%13.8M | 335.01%19.27M | 151.85%1.04M | 163.56%1.3M | 74.14%1.34M | -11.24%4.43M | -84.87%414.67K | -49.33%494.14K |
| Advance receipts | 154.44%993.47K | 263.24%1.33M | 19.72%643.91K | --169.36K | --390.45K | --366.97K | --537.86K | ---- | ---- | ---- |
| Salaries payable | -85.90%115.02K | -85.28%125.27K | -46.93%836.97K | -60.30%836.97K | 5.74%815.63K | 26.90%850.99K | 19.24%1.58M | 38.05%2.11M | -64.49%771.36K | -68.95%670.63K |
| Taxs payable | 59.66%1.28M | 62.03%1.44M | -59.43%820.99K | -47.31%2.96M | -81.07%803.56K | -84.15%887.9K | -51.64%2.02M | 43.47%5.62M | 64.43%4.24M | 356.42%5.6M |
| Other payable (including interest and dividends) | -15.96%27.74M | 1.94%29.24M | 7.10%35.03M | -1.00%34.67M | 6.17%33.01M | -16.05%28.68M | -10.39%32.71M | -8.24%35.02M | -2.32%31.09M | -5.30%34.17M |
| -Other payable | ---- | 1.94%29.24M | ---- | ---- | ---- | -16.05%28.68M | ---- | -8.24%35.02M | ---- | -5.30%34.17M |
| Non current liabilities due within one year | -48.37%8.83M | -30.57%8.82M | -53.40%8.83M | -58.82%8.81M | 38.43%17.11M | -38.31%12.71M | 10.80%18.94M | 25.16%21.4M | -7.74%12.36M | 108.89%20.6M |
| Other current liabilities | 563.11%488.55K | 4,272.89%1.96M | 76.81%43.28K | -43.47%60.6K | 36.67%73.68K | -30.15%44.87K | -75.50%24.48K | -83.48%107.19K | -84.80%53.91K | -49.33%64.24K |
| Total current liabilities | 23.83%77.33M | 48.82%81.11M | 4.01%70.05M | -1.04%76.97M | -8.27%62.45M | -32.46%54.51M | -13.47%67.34M | -14.41%77.78M | -17.51%68.08M | -1.54%80.7M |
| Current liabilities | ||||||||||
| Long term loan | -27.67%10.51M | -43.25%10.51M | -41.02%14.02M | -41.05%14.02M | -58.53%14.53M | -36.21%18.52M | -32.17%23.77M | -32.14%23.78M | 34.61%35.04M | 48.70%29.03M |
| Deferred tax liabilities | -60.92%192.92K | -34.70%340.67K | 41.68%363.84K | 22.05%545.02K | -1.17%493.61K | 107.55%521.69K | -14.73%256.81K | 571.15%446.56K | 47.72%499.45K | 199.47%251.35K |
| Long term deferred income | -23.88%280.5K | -22.54%302.5K | -21.33%324.5K | -20.25%346.5K | -19.28%368.5K | -18.39%390.5K | -17.58%412.5K | -16.84%434.5K | -16.16%456.5K | -15.53%478.5K |
| Lease liabilities | -61.91%493.61K | -58.27%705.16K | --831.6K | --831.6K | --1.3M | --1.69M | ---- | ---- | ---- | ---- |
| Total non current liabilities | -31.23%11.48M | -43.85%11.86M | -36.42%15.54M | -36.17%15.74M | -53.63%16.69M | -29.03%21.12M | -37.79%24.44M | -36.78%24.66M | 19.16%36M | 26.80%29.76M |
| Total liabilities | 12.22%88.81M | 22.93%92.97M | -6.75%85.59M | -9.50%92.71M | -23.96%79.14M | -31.54%75.63M | -21.63%91.79M | -21.13%102.44M | -7.69%104.08M | 4.77%110.47M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M | 0.00%219.7M |
| Capital reserve funds | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M | 0.00%117.8M |
| Surplus reserve funds | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M | 0.00%32.67M |
| Retained profit | -156.27%-8.78M | -105.93%-1.2M | -80.37%5.58M | -64.64%10.96M | -58.08%15.6M | -49.74%20.21M | -37.48%28.44M | -36.36%30.99M | -56.03%37.21M | -55.04%40.2M |
| Shareholders equity without minority interests | -6.32%361.39M | -5.48%368.97M | -5.73%375.75M | -4.99%381.12M | -5.31%385.77M | -4.87%390.37M | -4.10%398.6M | -4.23%401.16M | -10.43%407.38M | -10.71%410.37M |
| Total shareholder equity | -6.32%361.39M | -5.48%368.97M | -5.73%375.75M | -4.99%381.12M | -5.31%385.77M | -4.87%390.37M | -4.10%398.6M | -4.23%401.16M | -10.43%407.38M | -10.71%410.37M |
| Total liabilityies and equity | -3.16%450.2M | -0.87%461.94M | -5.92%461.34M | -5.91%473.83M | -9.10%464.91M | -10.53%466M | -7.95%490.39M | -8.23%503.6M | -9.88%511.46M | -7.82%520.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- | -- | Shinnaganaka & Chung Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data